NDC codes

FDA NDC Directory
Product NDC (as listed)72162-1640Labeler and product segments. Claims need a package NDC.
Product NDC at billing width72162-1640Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
72162-1640-0721621640001000 TABLET in 1 BOTTLE (72162-1640-0)Marketed from Jul 16, 2024
72162-1640-27216216400245 TABLET in 1 BOTTLE (72162-1640-2)Marketed from Aug 28, 2023
72162-1640-37216216400330 TABLET in 1 BOTTLE (72162-1640-3)Marketed from Aug 28, 2023
72162-1640-572162164005500 TABLET in 1 BOTTLE (72162-1640-5)Marketed from Aug 28, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Mirtazapine
Generic name (nonproprietary)
mirtazapine
Active ingredients
Mirtazapine — 30 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 076541
Marketing start
Listing expires
Identifiers
Product ID 72162-1640_ec83d85a-e001-4696-8049-cb3eaa90bed8SPL ID ec83d85a-e001-4696-8049-cb3eaa90bed8SPL set ID ded5b83b-f11a-4a6a-bf77-c5fe6dc4c4f5RxCUI 314111UNII A051Q2099Q

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162164000 followed by a unit qualifier and the quantity

Package 72162-1640-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ]. Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076541

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076541
ProductStrengthForm · routeLabelerProduct NDC
MirtazapineMirtazapine 15 mg/1TabletOralSun Pharmaceutical Industries, Inc.57664-499
MirtazapineMirtazapine 30 mg/1TabletOralAphena Pharma Solutions - Tennessee, LLC71610-713
MirtazapineMirtazapine 30 mg/1TabletOralSun Pharmaceutical Industries, Inc.57664-500
MirtazapineMirtazapine 45 mg/1TabletOralSun Pharmaceutical Industries, Inc.57664-501
MirtazapineMirtazapine 7.5 mg/1TabletOralSun Pharmaceutical Industries, Inc.57664-510
MirtazapineMirtazapine 30 mg/1TabletOralBryant Ranch Prepack71335-0441
MirtazapineMirtazapine 15 mg/1TabletOralBryant Ranch Prepack71335-0286
MirtazapineMirtazapine 30 mg/1TabletOralREMEDYREPACK INC.70518-4548
MirtazapineMirtazapine 30 mg/1TabletOralBryant Ranch Prepack71335-2963
MirtazapineMirtazapine 15 mg/1TabletOralBryant Ranch Prepack63629-2366
MirtazapineMirtazapine 7.5 mg/1TabletOralAvKARE42291-494
MirtazapineMirtazapine 15 mg/1TabletOralBryant Ranch Prepack63629-2367
MirtazapineMirtazapine 30 mg/1TabletOralBryant Ranch Prepack63629-2368
MirtazapineMirtazapine 15 mg/1TabletOralBryant Ranch Prepack72162-1639

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in